Americans trying to lose weight say they spent over $12,000 in a year. A new survey breaks down where the money goes and why it adds up.
Consumer365 has recognized Blue Apron as the best meal delivery service for weight loss, citing its flexible ordering model, balanced meal design, and system-driven approach to supporting healthier ...
When people stop taking the new generation of weight-loss drugs they pile back on the kilos four times faster than they would after ending diet and exercise regimens, new research found Thursday. But ...
Matt Damon, who stars as Greek warrior Odysseus in the upcoming Christopher Nolan adaptation of "The Odyssey," got candid on the diet hack that helped him slim down for the action-hero role during an ...
At this point, millions of people in the U.S. have tried at least one of a variety of glucagonlike peptide 1 (GLP-1) receptor agonist drugs such as Zepbound or Wegovy. For some, these medications have ...
Forbes contributors publish independent expert analyses and insights. Diane Omdahl is a Medicare expert who keeps her readers in the know. On December 23, the Centers for Medicare and Medicaid ...
Melissa McCarthy has been crushing it in Hollywood for years. From making a name for herself on television with beloved roles on Gilmore Girls and Mike and Molly to becoming a bonafide movie star in ...
A pill form of weight-loss drug Wegovy, manufactured by Danish drugmaker Novo Nordisk, is now available in the U.S., giving Americans access to an oral medication to treat obesity. The starting dose ...
For years, pharmaceutical companies have been racing to develop a market-ready GLP-1 weight-loss pill to join the ranks of popular injectables. Today, Novo Nordisk’s oral version of Wegovy is ...
Changes are coming in 2026 for GLP-1 drugs. Long defined by high prices, shortages and weekly injections, drugs including Wegovy and Zepbound are expected to be easier to access and afford. And new ...